SpringWorks Therapeutics
The Director, Value, Access & Pricing (VAP) GOMEKLI leads the U.S. Market Access team in developing and executing market access and pricing strategies for the GOMEKLI product. This role shapes access strategies, creates payer and provider tools, and collaborates with cross‑functional partners to ensure optimal product uptake and commercial success.
Headquarters
Stamford, Connecticut, United States
Company Size
201-500 employees
Founded
2017
SpringWorks Therapeutics, a healthcare company of Merck KGaA, Darmstadt, Germany, is a commercial-stage biopharmaceutical company focused on targeted oncology, including rare oncology and BCMA combinations in multiple myeloma. The company develops and commercializes treatments for patients with devastating cancers and rare diseases, with approved medicines including OGSIVEO® (nirogacestat) for desmoid tumors and EZMEKLY® (mirdametinib) for NF1-associated plexiform neurofibromas. SpringWorks combines scientific rigor with a patient-centric, urgency-driven approach to unlock the full potential of targeted oncology.
Merck Completes Acquisition of SpringWorks Therapeutics to Accelerate Sustainable Growth of its Healthcare Business
Jul 1, 2025
Merck KGaA drops pipeline assets from SpringWorks buyout, Hengrui licensing deal
1 week ago
Merck completes $3.4bn acquisition of SpringWorks Therapeutics
Jul 2, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for SpringWorks Therapeutics.
3% below the average for this role
Biopharma Co. Can't Beat Former Exec's Age, Race Bias Suit
3 days ago
Director, Global Value & Market Access
Alfasigma
Director, Value & Access Marketing
Digital Biology
Associate Director, Market Access Strategy
AstraZeneca
Director, Global Market Access
Alnylam Pharmaceuticals
Senior Director of Global Pricing, Value & Access
C0001163629T1
Senior Director, Metabolic Market Access Strategy & Marketing
Travere Therapeutics